Growth hormone-releasing hormone and its analogues in health and disease
Schally, A. V. et al. Actions and potential therapeutic applications of growth hormone-releasing hormone agonists. Endocrinology 160, 1600–1612 (2019).
Google Scholar
Granata, R. Peripheral activities of growth hormone-releasing hormone. J. Endocrinol. Invest. 39, 721–727 (2016).
Google Scholar
Schally, A. V., Steelman, S. L. & Bowers, C. Y. Effect of hypothalamic extracts on release of growth hormone in vitro. Proc. Soc. Exp. Biol. Med. 119, 208–212 (1965).
Google Scholar
Reichlin, S. Growth hormone content of pituitaries from rats with hypothalamic lesions. Endocrinology 69, 225–230 (1961).
Google Scholar
Schally, A. V. et al. Purification of growth hormone-releasing factor from beef hypothalamus. Proc. Soc. Exp. Biol. Med. 122, 821–823 (1966).
Google Scholar
Schally, A. V. et al. Isolation of growth hormone-releasing hormone (GRH) from porcine hypothalami. Endocrinology 84, 1493–1506 (1969).
Google Scholar
Frohman, L. A. & Szabo, M. Ectopic production of growth hormone-releasing factor by carcinoid and pancreatic islet tumors associated with acromegaly. Prog. Clin. Biol. Res. 74, 259–271 (1981).
Google Scholar
Rivier, J., Spiess, J., Thorner, M. & Vale, W. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 300, 276–278 (1982).
Google Scholar
Guillemin, R. et al. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218, 585–587 (1982).
Google Scholar
Ling, N. et al. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc. Natl Acad. Sci. USA 81, 4302–4306 (1984).
Google Scholar
Kiaris, H., Chatzistamou, I., Papavassiliou, A. G. & Schally, A. V. Growth hormone-releasing hormone: not only a neurohormone. Trends Endocrinol. Metab. 22, 311–317 (2011).
Google Scholar
Mayo, K. E. Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Mol. Endocrinol. 6, 1734–1744 (1992).
Google Scholar
Gaylinn, B. D. et al. Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. Mol. Endocrinol. 7, 77–84 (1993).
Google Scholar
Zhou, F. et al. Structural basis for activation of the growth hormone-releasing hormone receptor. Nat. Commun. 11, 5205 (2020).
Google Scholar
Rekasi, Z., Czompoly, T., Schally, A. V. & Halmos, G. Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. Proc. Natl Acad. Sci. USA 97, 10561–10566 (2000).
Google Scholar
Havt, A. et al. The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Proc. Natl Acad. Sci. USA 102, 17424–17429 (2005).
Google Scholar
Kiaris, H. et al. Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor. Proc. Natl Acad. Sci. USA 100, 9512–9517 (2003).
Google Scholar
Barabutis, N. et al. Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor. Proc. Natl Acad. Sci. USA 104, 5575–5579 (2007).
Google Scholar
Frohman, L. A. & Kineman, R. D. Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis. Trends Endocrinol. Metab. 13, 299–303 (2002).
Google Scholar
Ranke, M. B. & Wit, J. M. Growth hormone – past, present and future. Nat. Rev. Endocrinol. 14, 285–300 (2018).
Google Scholar
Barabutis, N. & Schally, A. V. Growth hormone-releasing hormone: extrapituitary effects in physiology and pathology. Cell Cycle 9, 4110–4116 (2010).
Google Scholar
Cai, R. et al. Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities. Peptides 52, 104–112 (2014).
Google Scholar
Granato, G. et al. Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells. Front. Immunol. 14, 1231363 (2023).
Google Scholar
Boido, M. et al. Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice. Proc. Natl Acad. Sci. USA 120, e2216814120 (2023).
Google Scholar
Liu, Y. et al. Agonistic analog of growth hormone-releasing hormone promotes neurofunctional recovery and neural regeneration in ischemic stroke. Proc. Natl Acad. Sci. USA 118, e2109600118 (2021).
Google Scholar
Schally, A. V., Varga, J. L. & Engel, J. B. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer. Nat. Clin. Pract. Endocrinol. Metab. 4, 33–43 (2008).
Google Scholar
Schally, A. V. & Varga, J. L. Antagonistic analogs of growth hormone-releasing hormone: new potential antitumor agents. Trends Endocrinol. Metab. 10, 383–391 (1999).
Google Scholar
Barabutis, N., Akhter, M. S., Kubra, K. T. & Jackson, K. Growth hormone-releasing hormone in endothelial inflammation. Endocrinology 164, bqac209 (2022).
Google Scholar
Zarandi, M. et al. Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth. Peptides 89, 60–70 (2017).
Google Scholar
Schally, A. V. et al. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH. Proc. Natl Acad. Sci. USA 115, 12028–12033 (2018).
Google Scholar
Izdebski, J. et al. Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. Proc. Natl Acad. Sci. USA 92, 4872–4876 (1995).
Google Scholar
Ludwig, B. et al. Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets. Proc. Natl Acad. Sci. USA 107, 12623–12628 (2010).
Google Scholar
Kanashiro-Takeuchi, R. M. et al. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc. Natl Acad. Sci. USA 107, 2604–2609 (2010).
Google Scholar
Dioufa, N. et al. Acceleration of wound healing by growth hormone-releasing hormone and its agonists. Proc. Natl Acad. Sci. USA 107, 18611–18615 (2010).
Google Scholar
Lucas, R. et al. Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema. Proc. Natl Acad. Sci. USA 109, 2084–2089 (2012).
Google Scholar
Grunfeld, C., Dritselis, A. & Kirkpatrick, P. Tesamorelin. Nat. Rev. Drug. Discov. 10, 95–96 (2011).
Google Scholar
Stanley, T. L. et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA 312, 380–389 (2014).
Google Scholar
Sato, K. et al. Synthetic analogs of growth hormone-releasing factor with antagonistic activity in vitro. Biochem. Biophys. Res. Commun. 167, 360–366 (1990).
Google Scholar
Coy, D. H., Hocart, S. J. & Murphy, W. A. Human growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cells. Eur. J. Pharmacol. 204, 179–185 (1991).
Google Scholar
Robberecht, P. et al. Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1,d-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. Endocrinology 117, 1759–1764 (1985).
Google Scholar
Pollak, M. N., Polychronakos, C. & Richard, M. Insulinlike growth factor I: a potent mitogen for human osteogenic sarcoma. J. Natl Cancer Inst. 82, 301–305 (1990).
Google Scholar
Zarandi, M. et al. Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities. Proc. Natl Acad. Sci. USA 103, 4610–4615 (2006).
Google Scholar
Varga, J. L. et al. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities. Proc. Natl Acad. Sci. USA 96, 692–697 (1999).
Google Scholar
Cai, R. et al. Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity. Peptides 150, 170716 (2022).
Google Scholar
Villanova, T. et al. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. Proc. Natl Acad. Sci. USA 116, 2226–2231 (2019).
Google Scholar
Wang, H. et al. Inhibition of experimental small-cell and non-small-cell lung cancers by novel antagonists of growth hormone-releasing hormone. Int. J. Cancer 142, 2394–2404 (2018).
Google Scholar
Gesmundo, I. et al. Antagonists of growth hormone-releasing hormone inhibit the growth of pituitary adenoma cells by hampering oncogenic pathways and promoting apoptotic signaling. Cancers 13, 3950 (2021).
Google Scholar
Gan, J. et al. Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1–STAT3/NF-κB signaling. Proc. Natl Acad. Sci. USA 113, 14745–14750 (2016).
Google Scholar
Barabutis, N. & Schally, A. V. Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line. Proc. Natl Acad. Sci. USA 105, 20470–20475 (2008).
Google Scholar
Zhang, C. et al. Growth hormone-releasing hormone in lung physiology and pulmonary disease. Cells 9, 2331 (2020).
Google Scholar
Barabutis, N., Schally, A. V. & Siejka, A. P53, GHRH, inflammation and cancer. EBioMedicine 37, 557–562 (2018).
Google Scholar
Ayhan-Sahin, B., Apaydin, Z. E., Obakan-Yerlikaya, P., Arisan, E. D. & Coker-Gurkan, A. Synthesis and characterization of novel ssDNA X-aptamers targeting growth hormone releasing hormone (GHRH). PLoS ONE 17, e0260144 (2022).
Google Scholar
Adachi, T. & Nakamura, Y. Aptamers: a review of their chemical properties and modifications for therapeutic application. Molecules 24, 4229 (2019).
Google Scholar
Juhasz, E. et al. Expression of growth hormone-releasing hormone and its receptor splice variants in a cohort of Hungarian pediatric patients with hematological and oncological disorders: a pilot study. Int. J. Mol. Sci. 25, 8831 (2024).
Google Scholar
Cong, Z. et al. Constitutive signal bias mediated by the human GHRHR splice variant 1. Proc. Natl Acad. Sci. USA 118, e2106606118 (2021).
Google Scholar
Lin, C., Lin, S. C., Chang, C. P. & Rosenfeld, M. G. Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth. Nature 360, 765–768 (1992).
Google Scholar
Gonigam, R. L. et al. Characterization of somatotrope cell expansion in response to GHRH in the neonatal mouse pituitary. Endocrinology 164, bqad131 (2023).
Google Scholar
Kahan, Z. et al. Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers. J. Clin. Endocrinol. Metab. 84, 582–589 (1999).
Google Scholar
Christodoulou, C. et al. Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues. Regul. Pept. 136, 105–108 (2006).
Google Scholar
Barabutis, N. & Schally, A. V. Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines. Br. J. Cancer 98, 1790–1796 (2008).
Google Scholar
Kiaris, H. et al. Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs. Proc. Natl Acad. Sci. USA 99, 196–200 (2002).
Google Scholar
Xiong, X. et al. Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target. Proc. Natl Acad. Sci. USA 117, 6726–6732 (2020).
Google Scholar
Pombo, C. M., Zalvide, J., Gaylinn, B. D. & Dieguez, C. Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. Endocrinology 141, 2113–2119 (2000).
Google Scholar
Barabutis, N. et al. Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor. J. Mol. Endocrinol. 44, 127–134 (2010).
Google Scholar
Siriwardana, G., Bradford, A., Coy, D. & Zeitler, P. Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Mol. Endocrinol. 20, 2010–2019 (2006).
Google Scholar
Siejka, A., Schally, A. V. & Barabutis, N. Activation of Janus kinase/signal transducer and activator of transcription 3 pathway by growth hormone-releasing hormone. Cell Mol. Life Sci. 67, 959–964 (2010).
Google Scholar
Barabutis, N., Siejka, A. & Schally, A. V. Growth hormone releasing hormone induces the expression of nitric oxide synthase. J. Cell Mol. Med. 15, 1148–1155 (2011).
Google Scholar
Munoz-Moreno, L., Carmena, M. J., Prieto, J. C., Schally, A. V. & Bajo, A. M. Tumorigenic transformation of human prostatic epithelial cell line RWPE-1 by growth hormone-releasing hormone (GHRH). Prostate 82, 933–941 (2022).
Google Scholar
Kiaris, H., Schally, A. V. & Armatis, P. Direct action of growth hormone-releasing hormone agonist JI-38 on normal human fibroblasts: evidence from studies on cell proliferation and c-myc proto-oncogene expression. Regul. Pept. 96, 119–124 (2001).
Google Scholar
Florea, V. et al. Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival. Proc. Natl Acad. Sci. USA 111, 17260–17265 (2014).
Google Scholar
Louzada, R. A. et al. GHRH agonist MR-409 protects β-cells from streptozotocin-induced diabetes. Proc. Natl Acad. Sci. USA 120, e2209810120 (2023).
Google Scholar
Zhang, X. et al. Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice. Proc. Natl Acad. Sci. USA 112, 13651–13656 (2015).
Google Scholar
Cui, T. et al. Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways. Oncotarget 7, 52661–52672 (2016).
Google Scholar
Hasegawa, J. et al. Positive inotropic effect of growth hormone releasing factor in the guinea-pig cardiac muscles in vitro. Horm. Metab. Res. 20, 130–131 (1988).
Google Scholar
Granata, R. et al. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart. Cardiovasc. Res. 83, 303–312 (2009).
Google Scholar
Bagno, L. L. et al. Growth hormone-releasing hormone agonists reduce myocardial infarct scar in swine with subacute ischemic cardiomyopathy. J. Am. Heart Assoc. 4, e001464 (2015).
Google Scholar
Kanashiro-Takeuchi, R. M. et al. Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction. Am. J. Physiol. Heart Circ. Physiol. 324, H739–H750 (2023).
Google Scholar
Isgaard, J., Arcopinto, M., Karason, K. & Cittadini, A. GH and the cardiovascular system: an update on a topic at heart. Endocrine 48, 25–35 (2015).
Google Scholar
Penna, C. et al. GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways. Endocrinology 154, 1624–1635 (2013).
Google Scholar
Kiscsatari, L. et al. Protection of neonatal rat cardiac myocytes against radiation-induced damage with agonists of growth hormone-releasing hormone. Pharmacol. Res. 111, 859–866 (2016).
Google Scholar
Kanashiro-Takeuchi, R. M. et al. New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor. Oncotarget 6, 9728–9739 (2015).
Google Scholar
Kanashiro-Takeuchi, R. M. et al. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI). Proc. Natl Acad. Sci. USA 109, 559–563 (2012).
Google Scholar
Pfeffer, M. A., Shah, A. M. & Borlaug, B. A. Heart failure with preserved ejection fraction in perspective. Circ. Res. 124, 1598–1617 (2019).
Google Scholar
Rieger, A. C. et al. Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction. Proc. Natl Acad. Sci. USA 118, e2019835118 (2021).
Google Scholar
Dulce, R. A. et al. Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction. Cardiovasc. Res. 118, 3586–3601 (2023).
Google Scholar
Gesmundo, I. et al. Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure. Proc. Natl Acad. Sci. USA 114, 12033–12038 (2017).
Google Scholar
Xiang, P. et al. Improvement of cardiac and systemic function in old mice by agonist of growth hormone-releasing hormone. J. Cell Physiol. 236, 8197–8207 (2021).
Google Scholar
Tomlinson, B., Wu, Q. Y., Zhong, Y. M. & Li, Y. H. Advances in dyslipidaemia treatments: focusing on ApoC3 and ANGPTL3 inhibitors. J. Lipid Atheroscler. 13, 2–20 (2024).
Google Scholar
Clemmons, D. R., Miller, S. & Mamputu, J. C. Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: a randomized, placebo-controlled trial. PLoS ONE 12, e0179538 (2017).
Google Scholar
Shen, J. et al. Regulation of vascular calcification by growth hormone-releasing hormone and its agonists. Circ. Res. 122, 1395–1408 (2018).
Google Scholar
Ren, H. L. et al. Growth hormone-releasing hormone agonist attenuates vascular calcification in diabetic db/db mice. Front. Cardiovasc. Med. 10, 1102525 (2023).
Google Scholar
Gomes, S. A. et al. S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells. Proc. Natl Acad. Sci. USA 110, 2834–2839 (2013).
Google Scholar
Ma, Q. et al. Profound actions of an agonist of growth hormone-releasing hormone on angiogenic therapy by mesenchymal stem cells. Arterioscler. Thromb. Vasc. Biol. 36, 663–672 (2016).
Google Scholar
Li, Z. et al. Growth hormone-releasing hormone promotes therapeutic effects of peripheral blood endothelial progenitor cells in ischemic repair. J. Endocrinol. Invest. 43, 315–328 (2020).
Google Scholar
Holt, R. I., Simpson, H. L. & Sonksen, P. H. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabet. Med. 20, 3–15 (2003).
Google Scholar
Kamenicky, P., Mazziotti, G., Lombes, M., Giustina, A. & Chanson, P. Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr. Rev. 35, 234–281 (2014).
Google Scholar
Romero, M. J. et al. Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes. Proc. Natl Acad. Sci. USA 113, 1895–1900 (2016).
Google Scholar
Bayne, M. et al. Repeated hypoglycemia remodels neural inputs and disrupts mitochondrial function to blunt glucose-inhibited GHRH neuron responsiveness. JCI Insight 5, e133488 (2020).
Google Scholar
Fridlyand, L. E., Tamarina, N. A., Schally, A. V. & Philipson, L. H. Growth hormone-releasing hormone in diabetes. Front. Endocrinol. 7, 129 (2016).
Google Scholar
Schmid, J. et al. Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11β-hydroxysteroid dehydrogenase. Proc. Natl Acad. Sci. USA 108, 13722–13727 (2011).
Google Scholar
Rodrigues-Dos-Santos, K. et al. Effects of growth hormone-releasing hormone agonistic analog MR-409 on insulin-secreting cells under cyclopiazonic acid-induced endoplasmic reticulum stress. Mol. Cell Endocrinol. 535, 111379 (2021).
Google Scholar
Kulkarni, A., Muralidharan, C., May, S. C., Tersey, S. A. & Mirmira, R. G. Inside the β cell: molecular stress response pathways in diabetes pathogenesis. Endocrinology 164, bqac184 (2022).
Google Scholar
Drucker, D. J. & Holst, J. J. The expanding incretin universe: from basic biology to clinical translation. Diabetologia 66, 1765–1779 (2023).
Google Scholar
Kim, S. H. & Park, M. J. Effects of growth hormone on glucose metabolism and insulin resistance in human. Ann. Pediatr. Endocrinol. Metab. 22, 145–152 (2017).
Google Scholar
Czarnecka, Z., Dadheech, N., Razavy, H., Pawlick, R. & Shapiro, A. M. J. The current status of allogenic islet cell transplantation. Cells 12, 2423 (2023).
Google Scholar
Ludwig, B. et al. Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc. Natl Acad. Sci. USA 109, 5022–5027 (2012).
Google Scholar
Schubert, U. et al. Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone. Proc. Natl Acad. Sci. USA 110, 2288–2293 (2013).
Google Scholar
Muller, T. D., Bluher, M., Tschop, M. H. & DiMarchi, R. D. Anti-obesity drug discovery: advances and challenges. Nat. Rev. Drug. Discov. 21, 201–223 (2022).
Google Scholar
Stanley, T. L. & Grinspoon, S. K. Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies. Growth Horm. IGF Res. 25, 59–65 (2015).
Google Scholar
Rodríguez-Pacheco, F. et al. Growth hormone-releasing hormone is produced by adipocytes and regulates lipolysis through growth hormone receptor. Int. J. Obes. 41, 1547–1555 (2017).
Google Scholar
Recinella, L. et al. Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases. Front. Physiol. 11, 578966 (2020).
Google Scholar
Decourtye-Espiard, L. et al. Stimulation of GHRH neuron axon growth by leptin and impact of nutrition during suckling in mice. Nutrients 15, 1077 (2023).
Google Scholar
Recinella, L. et al. Growth hormone-releasing hormone antagonistic analog MIA-690 stimulates food intake in mice. Peptides 142, 170582 (2021).
Google Scholar
Muller, T. D. et al. Ghrelin. Mol. Metab. 4, 437–460 (2015).
Google Scholar
Casanueva, F. F. et al. Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a. Proc. Natl Acad. Sci. USA 105, 20452–20457 (2008).
Google Scholar
Sapkota, S. et al. GHRH neurons from the ventromedial hypothalamic nucleus provide dynamic and sex-specific input to the brain glucose-regulatory network. Neuroscience 529, 73–87 (2023).
Google Scholar
Muller, E. E., Locatelli, V. & Cocchi, D. Neuroendocrine control of growth hormone secretion. Physiol. Rev. 79, 511–607 (1999).
Google Scholar
Vitiello, M. V. et al. Growth hormone releasing hormone improves the cognition of healthy older adults. Neurobiol. Aging 27, 318–323 (2006).
Google Scholar
Chang, Y. et al. A potentially effective drug for patients with recurrent glioma: sermorelin. Ann. Transl. Med. 9, 406 (2021).
Google Scholar
Baker, L. D. et al. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch. Neurol. 69, 1420–1429 (2012).
Google Scholar
Friedman, S. D. et al. Growth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging. JAMA Neurol. 70, 883–890 (2013).
Google Scholar
Banks, W. A. et al. Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice. Proc. Natl Acad. Sci. USA 107, 22272–22277 (2010).
Google Scholar
Telegdy, G., Tanaka, M. & Schally, A. V. Effects of the growth hormone-releasing hormone (GH-RH) antagonist on brain functions in mice. Behav. Brain Res. 224, 155–158 (2011).
Google Scholar
Recinella, L. et al. Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice. Sci. Rep. 10, 732 (2020).
Google Scholar
Recinella, L. et al. Effects of growth hormone-releasing hormone receptor antagonist MIA-602 in mice with emotional disorders: a potential treatment for PTSD. Mol. Psychiatry 26, 7465–7474 (2021).
Google Scholar
Recinella, L. et al. Effects of GHRH deficiency and GHRH antagonism on emotional disorders in mice. Cells 12, 2615 (2023).
Google Scholar
Jaszberenyi, M. et al. Beneficial effects of novel antagonists of GHRH in different models of Alzheimer’s disease. Aging 4, 755–767 (2012).
Google Scholar
Oglodek, E. A. & Just, M. J. The association between inflammatory markers (iNOS, HO-1, IL-33, MIP-1β) and depression with and without posttraumatic stress disorder. Pharmacol. Rep. 70, 1065–1072 (2018).
Google Scholar
Rakofsky, J. J., Ressler, K. J. & Dunlop, B. W. BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity. Mol. Psychiatry 17, 22–35 (2012).
Google Scholar
Hallschmid, M., Wilhelm, I., Michel, C., Perras, B. & Born, J. A role for central nervous growth hormone-releasing hormone signaling in the consolidation of declarative memories. PLoS ONE 6, e23435 (2011).
Google Scholar
Diano, S. et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat. Neurosci. 9, 381–388 (2006).
Google Scholar
Pedrolli, F. et al. Protective effect of growth hormone-releasing hormone (GHRH) and its agonistic analog MR-409 in Alzheimer’s disease [abstract]. Endocr. Abstr. 99, OC13.4 (2024).
Gallo, D. et al. GH-releasing hormone promotes survival and prevents TNF-α-induced apoptosis and atrophy in C2C12 myotubes. Endocrinology 156, 3239–3252 (2015).
Google Scholar
Mercuri, E., Pera, M. C., Scoto, M., Finkel, R. & Muntoni, F. Spinal muscular atrophy – insights and challenges in the treatment era. Nat. Rev. Neurol. 16, 706–715 (2020).
Google Scholar
Dubovy, S. R. et al. Expression of hypothalamic neurohormones and their receptors in the human eye. Oncotarget 8, 66796–66814 (2017).
Google Scholar
Thounaojam, M. C. et al. Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy. Proc. Natl Acad. Sci. USA 114, 13248–13253 (2017).
Google Scholar
Cen, L. P. et al. Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury. Proc. Natl Acad. Sci. USA 118, e1920834118 (2021).
Google Scholar
Liang, W. C. et al. Signaling mechanisms of growth hormone-releasing hormone receptor in LPS-induced acute ocular inflammation. Proc. Natl Acad. Sci. USA 117, 6067–6074 (2020).
Google Scholar
Qin, Y. J. et al. Antagonist of GH-releasing hormone receptors alleviates experimental ocular inflammation. Proc. Natl Acad. Sci. USA 111, 18303–18308 (2014).
Google Scholar
Chu, W. K. et al. Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells. Proc. Natl Acad. Sci. USA 113, 14396–14401 (2016).
Google Scholar
Du, L. et al. Growth hormone releasing hormone signaling promotes Th17 cell differentiation and autoimmune inflammation. Nat. Commun. 14, 3298 (2023).
Google Scholar
Saper, C. B., Fuller, P. M., Pedersen, N. P., Lu, J. & Scammell, T. E. Sleep state switching. Neuron 68, 1023–1042 (2010).
Google Scholar
Zhang, J. et al. Intrapreoptic microinjection of GHRH or its antagonist alters sleep in rats. J. Neurosci. 19, 2187–2194 (1999).
Google Scholar
Obal, F. Jr. & Krueger, J. M. GHRH and sleep. Sleep. Med. Rev. 8, 367–377 (2004).
Google Scholar
Steiger, A. et al. Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 56, 566–573 (1992).
Google Scholar
Ju, Y. E., Lucey, B. P. & Holtzman, D. M. Sleep and Alzheimer disease pathology – a bidirectional relationship. Nat. Rev. Neurol. 10, 115–119 (2014).
Google Scholar
Liao, F., Zhang, T. J., Mahan, T. E., Jiang, H. & Holtzman, D. M. Effects of growth hormone-releasing hormone on sleep and brain interstitial fluid amyloid-β in an APP transgenic mouse model. Brain Behav. Immun. 47, 163–171 (2015).
Google Scholar
Pedrolli, F. et al. Growth hormone-releasing hormone (GHRH) promotes survival and proliferation of neural stem cells and reduces amyloid-β-induced toxicity [abstract]. Endocr. Abstr. 81, P436 (2022).
Lyu, X., Wang, G., Pi, Z. & Wu, L. Acute sleep deprivation leads to growth hormone (GH) resistance in rats. Gen. Comp. Endocrinol. 296, 113545 (2020).
Google Scholar
Vaccarino, F. J., Bloom, F. E., Rivier, J., Vale, W. & Koob, G. F. Stimulation of food intake in rats by centrally administered hypothalamic growth hormone-releasing factor. Nature 314, 167–168 (1985).
Google Scholar
Imaki, T. et al. The satiety effect of growth hormone-releasing factor in rats. Brain Res. 340, 186–188 (1985).
Google Scholar
Lathe, R. Hormones and the hippocampus. J. Endocrinol. 169, 205–231 (2001).
Google Scholar
Murray, P. G., Higham, C. E. & Clayton, P. E. 60 years of neuroendocrinology: the hypothalamo-GH axis: the past 60 years. J. Endocrinol. 226, T123–T140 (2015).
Google Scholar
Olsen, J. et al. Intimate associations between the endogenous opiate systems and the growth hormone-releasing hormone system in the human hypothalamus. Neuroscience 258, 238–245 (2014).
Google Scholar
Honegger, J. et al. Interleukin-β modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and interleukin-6 have no effect. Endocrinology 129, 1275–1282 (1991).
Google Scholar
Talhouk, R. S., Saade, N. E., Mouneimne, G., Masaad, C. A. & Safieh-Garabedian, B. Growth hormone releasing hormone reverses endotoxin-induced localized inflammatory hyperalgesia without reducing the upregulated cytokines, nerve growth factor and gelatinase activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 625–631 (2004).
Google Scholar
Leone, S. et al. Increased pain and inflammatory sensitivity in growth hormone-releasing hormone (GHRH) knockout mice. Prostaglandins Other Lipid Mediat. 144, 106362 (2019).
Google Scholar
Recinella, L. et al. Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice. Sci. Rep. 11, 2530 (2021).
Google Scholar
Guevara-Aguirre, J. et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 3, 70ra13 (2011).
Google Scholar
Milman, S. et al. Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity. Aging Cell 13, 769–771 (2014).
Google Scholar
Milman, S., Huffman, D. M. & Barzilai, N. The somatotropic axis in human aging: framework for the current state of knowledge and future research. Cell Metab. 23, 980–989 (2016).
Google Scholar
Iovino, M. et al. Difference in growth hormone response to growth hormone-releasing hormone (GHRH) testing following GHRH subacute treatment in normal aging and growth hormone-deficient adults: possible perspectives for therapeutic use of GHRH or its analogs in elderly subjects? Immunopharmacol. Immunotoxicol. 33, 334–337 (2011).
Google Scholar
Weigent, D. A. Expression of lymphocyte-derived growth hormone (GH) and GH-releasing hormone receptors in aging rats. Cell Immunol. 282, 71–78 (2013).
Google Scholar
Nyberg, F. & Hallberg, M. Growth hormone and cognitive function. Nat. Rev. Endocrinol. 9, 357–365 (2013).
Google Scholar
Thornton, P. L., Ingram, R. L. & Sonntag, W. E. Chronic [D-Ala2]-growth hormone-releasing hormone administration attenuates age-related deficits in spatial memory. J. Gerontol. A Biol. Sci. Med. Sci. 55, B106–B112 (2000).
Google Scholar
Ye, R. et al. GHRH expression plasmid improves osteoporosis and skin damage in aged mice. Growth Horm. IGF Res. 60-61, 101429 (2021).
Google Scholar
Bartke, A., Sun, L. Y. & Longo, V. Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. Physiol. Rev. 93, 571–598 (2013).
Google Scholar
Sun, L. Y. et al. Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice. Elife 2, e01098 (2013).
Google Scholar
Lasher, A. T. & Sun, L. Y. Distinct physiological characteristics and altered glucagon signaling in GHRH knockout mice: implications for longevity. Aging Cell 22, e13985 (2023).
Google Scholar
Lasher, A. T., Wang, L., Hyun, J., Summers, S. A. & Sun, L. Y. Unveiling ceramide dynamics: shedding light on healthy aging in growth hormone-releasing hormone knockout mice. Aging Cell 23, e14226 (2024).
Google Scholar
Adkins-Jablonsky, J., Lasher, A. T., Patki, A., Nagarajan, A. & Sun, L. Y. Growth hormone-releasing hormone deficiency confers extended lifespan and metabolic resilience during high-fat feeding in mid and late life. Aging Cell 23, e14238 (2024).
Google Scholar
Hoffman, J. M. et al. Transcriptomic and metabolomic profiling of long-lived growth hormone releasing hormone knock-out mice: evidence for altered mitochondrial function and amino acid metabolism. Aging 12, 3473–3485 (2020).
Google Scholar
Leone, S. et al. Behavioural phenotyping of male growth hormone-releasing hormone (GHRH) knockout mice. Growth Horm. IGF Res. 24, 192–197 (2014).
Google Scholar
Leone, S. et al. Behavioural phenotyping, learning and memory in young and aged growth hormone-releasing hormone-knockout mice. Endocr. Connect. 7, 924–931 (2018).
Google Scholar
Aguiar-Oliveira, M. H. & Salvatori, R. Disruption of the GHRH receptor and its impact on children and adults: the Itabaianinha syndrome. Rev. Endocr. Metab. Disord. 22, 81–89 (2021).
Google Scholar
Batista, V. O. et al. Cognitive performance during senescence in untreated congenital isolated GH deficiency. Endocr. Connect. 13, e230401 (2024).
Google Scholar
Aguiar-Oliveira, M. H. & Bartke, A. Growth hormone deficiency: health and longevity. Endocr. Rev. 40, 575–601 (2019).
Google Scholar
Catanuto, P. et al. Expression of receptors for pituitary-type growth hormone-releasing hormone (pGHRH-R) in human papillary thyroid cancer cells: effects of GHRH antagonists on matrix metalloproteinase-2. Horm. Cancer 6, 100–106 (2015).
Google Scholar
Buchholz, S. et al. Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel. Proc. Natl Acad. Sci. USA 104, 1943–1946 (2007).
Google Scholar
Guo, J., Schally, A. V., Zarandi, M., Varga, J. & Leung, P. C. Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway. Reprod. Biol. Endocrinol. 8, 54 (2010).
Google Scholar
Engel, J. B. et al. Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone. J. Clin. Endocrinol. Metab. 90, 3614–3621 (2005).
Google Scholar
Fahrenholtz, C. D. et al. Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer. Proc. Natl Acad. Sci. USA 111, 1084–1089 (2014).
Google Scholar
Ziegler, C. G. et al. Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues. Proc. Natl Acad. Sci. USA 106, 15879–15884 (2009).
Google Scholar
Recinella, L. et al. Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice. Biomed. Pharmacother. 146, 112554 (2022).
Google Scholar
Jaszberenyi, M. et al. Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro. Target. Oncol. 8, 281–290 (2013).
Google Scholar
Szalontay, L. et al. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function. Cell Cycle 13, 2790–2797 (2014).
Google Scholar
Gesmundo, I. et al. Antagonist of growth hormone-releasing hormone potentiates the antitumor effect of pemetrexed and cisplatin in pleural mesothelioma. Int. J. Mol. Sci. 23, 11248 (2022).
Google Scholar
Jimenez, J. J. et al. A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone. Br. J. Haematol. 181, 476–485 (2018).
Google Scholar
Keller, G. et al. Effective treatment of experimental human non-Hodgkin’s lymphomas with antagonists of growth hormone-releasing hormone. Proc. Natl Acad. Sci. USA 102, 10628–10633 (2005).
Google Scholar
Kiaris, H. & Chatzistamou, I. Inhibition of tumor growth by agonists of growth hormone-releasing hormone. Proc. Natl Acad. Sci. USA 115, 11876–11878 (2018).
Google Scholar
Schally, A. V., Block, N. L. & Rick, F. G. Discovery of LHRH and development of LHRH analogs for prostate cancer treatment. Prostate 77, 1036–1054 (2017).
Google Scholar
Zhang, C. et al. Growth hormone-releasing hormone receptor antagonist modulates lung inflammation and fibrosis due to bleomycin. Lung 197, 541–549 (2019).
Google Scholar
Cui, T. et al. Alveolar epithelial cell growth hormone releasing hormone receptor in alveolar epithelial inflammation. Exp. Lung Res. 49, 152–164 (2023).
Google Scholar
Zhang, C. et al. Activity of the growth hormone-releasing hormone antagonist MIA602 and its underlying mechanisms of action in sarcoidosis-like granuloma. Clin. Transl. Immunol. 10, e1310 (2021).
Google Scholar
Barabutis, N. Growth hormone releasing hormone in endothelial barrier function. Trends Endocrinol. Metab. 32, 338–340 (2021).
Google Scholar
Akhter, M. S., Uddin, M. A., Schally, A. V., Kubra, K. T. & Barabutis, N. Involvement of the unfolded protein response in the protective effects of growth hormone releasing hormone antagonists in the lungs. J. Cell Commun. Signal. 15, 125–129 (2021).
Google Scholar
Condor Capcha, J. M. et al. Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice. Proc. Natl Acad. Sci. USA 120, e2308342120 (2023).
Google Scholar
Rick, F. G. et al. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia. Proc. Natl Acad. Sci. USA 108, 3755–3760 (2011).
Google Scholar
Popovics, P., Schally, A. V., Salgueiro, L., Kovacs, K. & Rick, F. G. Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells. Proc. Natl Acad. Sci. USA 114, 1359–1364 (2017).
Google Scholar
link
